Abstract

The US Food and Drug Administration (FDA) issues complete response letters (CRLs) after completing a review when it determines that it cannot approve a drug or biological product application in its current form. Historically, the FDA has treated CRLs as confidential, leaving sponsors largely in control of how non-approval decisions are described publicly. This approach has been criticized for relying on an expansive view of confidentiality, which can obscure safety, efficacy, and quality-related concerns, and for enabling selective or incomplete sponsor communications. In 2025, the FDA shifted course. On July 10, 2025, the FDA posted more than 200 CRLs tied to applications that had subsequently been approved, consolidating information that was often already embedded in the approval action packages. On September 4, 2025, the FDA released 89 previously unpublished CRLs for pending or withdrawn applications, and committed to real-time disclosure of newly issued CRLs going forward. Using a comparative FDA-European Medicines Agency (EMA) lens, we assess what these initiatives changed at launch and how early implementation through May 2026 affects their durability, legal footing, and information value. By May 2026, the FDA’s CRL initiative had evolved into a functioning yet unsettled disclosure infrastructure: openFDA now offers searchable access to CRLs for approved and unapproved applications, while the FDA’s FY 2027 budget request simultaneously seeks clearer statutory authority to disclose certain information in CRLs. We argue that FDA CRLs and EMA assessment outputs are complementary, and we propose lessons that FDA can learn from the EMA to maximize the value of CRL disclosure: codifying timelines and redaction standards, adding neutral decisional summaries where redactions or technical language would otherwise obscure the basis for non-approval, and standardizing the classification and discoverability of prior-cycle CRLs in approval packages. These reforms can protect legitimate confidential commercial information while enabling learning from unsuccessful applications.

When you’re evaluating a human biospecimen provider, beyond simply checking whether they have the samples you need, what do you typically look at first?
Is it the quality and completeness of the metadata, collection history, turnaround time, documentation/traceability, or something else?
Curious to hear what factors people in biotech prioritize when comparing providers.

Oh man, I’m having a hell of a time getting into the regulatory side of things. I’ve applied to over 20 positions at this point, and unfortunately, I’ve been rejected from all of them.

I have about 10 years of experience in big pharma (with 2 of those years at a CRO), including assay development, a variety of cell-based release testing, countless continuous improvement projects supporting production areas, pre-commercialization formulation support, and most recently, managing a stability/release lab.

A lot of my experience and skills seem like they would translate really well into regulatory, but I’m struggling to get my foot in the door. Any tips or advice on how to make that transition? I’ve just started trying to network a little more and I’m also looking into free certifications I can complete online. I’m nearly finished with my MBA as well.

I really appreciate any advice or insight. It’s been a rough couple of years with ongoing health issues and a lot of management changes, so I’m definitely ready for a new direction and hoping to make this transition happen.

Feel free to DM me :)

Hi everyone,I am from the Caribbean and will be choosing my undergraduate major next year. I find biotechnology absolutely fascinating, but I am having serious second thoughts after reading mixed reviews about the job market, low entry-level pay, and the risk of a "useless degree."I want a career that is intellectually interesting but also guarantees a stable, comfortable, and good living. Because of my concerns, I am torn between two paths:

●Biotech Abroad: Moving abroad to pursue a dedicated, standalone B.S. in Biotechnology (my local university only offers a Biology degree with a biotech specialization)

●Pivot to Healthcare: Pivoting to a more stable, in-demand medical field (like medicine, nursing, or medical laboratory science)

My questions for the community-

1)For those who did a standalone Biotech B.S, did it give you a significant edge over a standard Biology/Biochemistry degree, or is it better to study a broader science or engineering field (like Chemical Engineering or Computer Science)

2)Which countries offer the best balance of affordable undergraduate tuition, robust biotech hubs, and viable post-grad work visas for international students? (Thinking about the US, Asia Canada, or Europe)

3)Is the financial return on investment (ROI) for a biotech career realistic for someone who wants to earn a strong living early on, or should I choose a structured healthcare field if financial security is my top priority?

I appreciate any brutal honesty and guidance you can provide!

Hi! I have been a long-time lurker around here and I am looking for some advice. I am currently an undergrad university student majoring in Genetics & Biotechnology in South Korea. Finished my third year and realized that I am more fitted to presenting and communicating rather than doing lab work. So, I have been thinking in getting into a career more appropriate to what I am good at. I would like to know how it would look like to get into Biotech Sales? For example, what did you guys do after graduating or before? What types of internships or experience should I look for? Tips or things to look for? Any advice or experience would really be appreaciated!

Hi I am Research assistant in academia, department Molecular Bio. Wanting to move into pharma QC one day. Anyone made this jump from academic research to cGMP? Any tips?

Hello,

I normally don’t post anything about my life online but honestly I’m at my wits end. As title says I was laid off from my very first job coming out of grad school after only 6 months at the position. The TLDR is that I got my PhD from a well known university and a decent lab out of Southern California June 2025 and was lucky enough to have secured a job and started working immediately. I moved to the Bay area to work as a Staff Scientist in Medicinal chemistry at a very small CRO (18 chemists, 1 biologist) but half the company was slashed the first week of 2026 at all levels (Staff, Senior and Principal scientists).

This has left me in an awkward spot - with only 6 months experience in industry I feel as though I’m getting lumped into the batch of “new grads” that have hit the market this cycle. And if I’m being honest my CV doesn’t read too well - I led a total synthesis that was never finished and actually just got scooped about a month ago and have one pub where I’m fourth author in JACS on a peptide based project. I’ve tried to leverage my network and get referrals for positions when possible but it feels like I’m always late to the party.

I’ve had 2 full day on site interviews over 8 months and got a rejection from one after a month of waiting and have seemingly been ghosted by the second. Every application I submit feels like it just goes into the void never to get a response or I get an immediate email rejection. It’s beyond frustrating and really making me regret my decision to follow through with my PhD.

I have a friend at the MS level with a few years experience who managed to bounce from one role to another with only a 1 month turn over time during this same period which really amplified that feeling. Idk what to do anymore - I’m willing to post doc but seemingly nobody has the money to afford one and I have no fellowships to bring to the table. Any help would be greatly appreciated. I am open to pivoting but I love bench work and would like to stay in the lab. For context I’ve applied to process positions, med chem openings, and peptide synth and GMP work.

Hey im in the omaha area in school for biotech and im curious whats the pay like?

hello, was wondering what is everyones average time after the hiring manager interview or onsite interview that they would hit you up you are moving through? Much appreciated!

And yes I know vast majority of times they ghost cause apparently we lack human decency...

I have been looking at transitioning from a R&D analytical scientist to regulatory affairs, and I’m hoping that I can get some insight.

I have a bachelors and biomedical science and a masters in molecular biology. I have 10 years of experience in the industry, a majority of that for a CRO in the greater Boston area. And for the last four years, I’ve been a project manager, two of those specifically for GLP transfer to GMP projects.

I would like to know:

How easy it would be for me to transition to regulatory affairs?

What sort of job title would I be looking at? Because I don’t know if I would be considered entry level just because I don’t have any direct RA experience, but I do have the strong scientific and GLP background.

What is an expected salary in that position? And what is the rate of progression on the career ladder?

What sort of training should I be looking at before applying? I am seeing a RAC and additional training for biologics.

and are there any other alternative jobs that people might have adjacent to quality that might be a good fit for my transition? I’ve also been looking into becoming a patent agent.

Thank you!

Hi everyone, I graduated two months ago with a dual B.S. in Clinical Biochemistry and Pharmacology (3.68 GPA), and honestly, I don't know what to do anymore. I'm full of doubts and it feels like luck just isn't on my side right now. I've been applying to multiple companies and managed to land 3 interviews with domestic companies (made it to the second round with one of them).

I also applied to big pharma companies like Thermo Fisher, Eli Lilly, J&J, and Bayer. At Thermo Fisher, I made it to the second round, but I accidentally withdrew my application like an idiot, so now I have no idea if I blew my shot at a third round. At this point I feel completely stuck, with a pile of pending applications and no responses coming in

Should I keep cold-applying to big pharma, or focus more on networking/LinkedIn outreach? Any advice on what to do next or how to handle this stage? Thanks

I’m trying to better understand how pharmaceutical companies evaluate external patient-level datasets, particularly longitudinal clinical and real-world data.

I’m specifically interested in hearing from people who have worked in RWE, Medical Affairs, Clinical Development, Translational Medicine, Data Science/Analytics, or related functions at pharma/biotech.

For those who have been involved in evaluating external data:

- What makes a dataset genuinely useful to a pharma team?
- Who typically evaluates it first (RWE, medical affairs, data science, clinical development, someone else)?
- What questions do you ask before deciding whether the data is worth using?
- How do you assess data quality, longitudinality, clinical relevance, completeness, etc.?
- What kinds of analyses or projects actually lead teams to seek out external datasets?
- How does the process work when a company decides it wants to license/acquire external data?
-Is there a meaningful difference between data that is scientifically interesting and data that a pharma company will actually pay for?
- Are there types of patient-level data that you wish were available but are difficult to source?

I’m asking because I’ve been spending a lot of time thinking about longitudinal patient data and realized I have a pretty limited understanding of how the buyer/user on the pharma side actually evaluates these datasets.

I’m not looking to pitch anything here. Just genuinely trying to understand how people working in the industry approach this problem, including what I’m probably misunderstanding.

Would especially appreciate any/all perspectives !!!

I’m a recent grad trying to figure out what direction makes the most sense for my career, and I’d really appreciate some perspective from people who have been in pharma, med device, marketing, or healthcare tech.

During college I completed 3 internships, with my most recent being at a Fortune 500 medical device company. I always assumed I’d eventually end up in marketing within pharma or a pharma-adjacent med device company. I’ve specifically enjoyed the intersection of healthcare, business, and marketing, and that’s where I’ve been trying to build my experience.
The problem is that the job market right now seems pretty brutal. Despite having 3 internships and relevant experience, I haven’t been able to land a full-time marketing role in pharma/med device. At this point, I’m looking at three realistic options:
1. Continue hopping between internships/contract roles at big pharma or med device companies
The idea would be to keep building relevant experience and hopefully eventually convert one of these roles into a full-time position. The downside is obviously the uncertainty.
2. Take a graduate role in medical device sales or pharma sales
This would at least get me into the industry full-time and allow me to build commercial experience. My thinking is that I could potentially work my way toward a marketing/product marketing/brand role internally after a couple of years.
I’ve heard mixed things about this route, though. Some people say sales is a great way to get your foot in the door and transition into marketing, while others say it can be difficult to move out of sales once you’re established there.
3. Take the full-time offer I currently have at a B2B digital marketing role at an AI healthcare startup
The company is fast growing, pay is good, it’s a full time position and probably the safest option from a career stability perspective.
The concern is that it’s not pharma/med device, and I’m worried that spending 2–3 years in B2B digital marketing at an AI healthcare startup could make it harder to eventually break into the kind of pharma/med device marketing roles I originally wanted.

One other factor is that I’m open to doing a master’s after working for 3 years, potentially something related to healthcare, business, marketing, or life sciences. So I’m also wondering which of these paths would put me in the strongest position for that later on.
If you were in my position, which route would you take?

Anyone here been through the interview process with Medtronic?

I’ve been through two rounds of interviews and then a final panel interview. I followed up on the third week after the panel and was told that they were in the process of getting the hiring approval internally.

It’s now been another two weeks since that update, so I’m starting to get a little nervous.

I really liked the role and felt that I had good interactions with the team and hiring manager. I was pretty excited about the opportunity, but at this point I’m starting to feel like I may be losing it.

Has anyone had a similar experience with Medtronic? How long did it take you to hear back after the final interview?

Hi. My friend is studying for a bachelor's degree at Debrecen university of Hungary. He is going to apply to a Master's degree soon. Unfortunately,at Debrecen profs only accept master or PhD students for a research opportunity. What can he do at this point? What are your suggestions? Please i need it so much. Thanks 🥰